What is the recommended treatment for a malignant lesion (Marjolin ulcer) arising in a diabetic foot?

Treatment of Malignant Lesions (Marjolin Ulcer) in Diabetic Foot

Wide surgical excision with adequate margins is the definitive treatment for squamous cell carcinoma arising in a diabetic foot ulcer (Marjolin ulcer), and amputation may be necessary to achieve tumor-free margins. 1, 2

Immediate Diagnostic Confirmation

• Perform punch biopsy or excisional biopsy of any chronic diabetic foot ulcer that fails to heal despite 6 weeks of optimal standard care, or any ulcer with suspicious features (raised edges, irregular borders, friable tissue, unusual appearance). 1, 2
• Marjolin ulcers typically arise in chronic wounds after prolonged periods—often decades—of inflammation or scarring, with squamous cell carcinoma being the most common malignancy. 1, 2
• These malignancies are twice as common in females and most frequently occur in the lower extremity, particularly the feet. 1

Surgical Management (Primary Treatment)

Wide Local Excision

• Execute wide local excision as the primary treatment, ensuring adequate tumor margins in both width and depth to prevent recurrence and metastasis. 1, 2
• The adequacy of margin excision is critical—insufficient margins lead to local recurrence and potential metastatic spread. 1
• If wide excision cannot achieve tumor-free margins while preserving limb function, proceed with amputation at a level that ensures complete tumor removal. 1, 2

Lymph Node Management

• Perform regional lymph node dissection if palpable lymph nodes are present on physical examination. 2
• Consider elective lymph node dissection if the tumor is poorly differentiated or high-grade, as these features indicate increased metastatic potential and poor prognosis. 2
• Lymph node metastases and high tumor grade are associated with significantly worse outcomes. 2

Concurrent Diabetic Foot Management

Vascular Assessment (Critical Before Surgery)

• Immediately assess arterial perfusion with ankle-brachial index (ABI), toe pressures, and transcutaneous oxygen pressure (TcPO₂) before planning surgical excision. 3, 4
• If ABI <0.5, ankle pressure <50 mmHg, toe pressure <30 mmHg, or TcPO₂ <25 mmHg, urgent revascularization must precede or accompany surgical excision to ensure wound healing. 3, 4
• The goal is restoration of direct arterial flow to at least one foot artery to support post-surgical healing. 4

Infection Control

• Assess for deep infection by probing to bone, checking for purulent drainage, and evaluating systemic signs (fever, elevated white blood cell count). 3, 4
• If moderate or severe infection is present, initiate empiric parenteral broad-spectrum antibiotics covering gram-positive organisms (including MRSA), gram-negative bacteria, and anaerobes before surgical intervention. 3
• Urgently perform surgical debridement to remove all infected and necrotic tissue, including infected bone if osteomyelitis is present. 3

Post-Surgical Wound Care

• After tumor excision, perform sharp debridement of the surgical wound at every visit to remove any necrotic tissue or slough. 3, 5
• Apply moisture-balancing dressings selected based on exudate control, comfort, and cost—avoid antimicrobial dressings unless active infection is present. 3, 6, 5
• Implement strict non-weight-bearing with a non-removable knee-high offloading device (total contact cast or irremovable walker) for post-operative wounds on weight-bearing surfaces. 3, 5
• Consider negative pressure wound therapy to reduce wound size and accelerate healing of post-surgical wounds. 3, 5

Systemic and Metabolic Optimization

• Optimize glycemic control with target blood glucose <140 mg/dL (<8 mmol/L) to support wound healing. 5, 7
• Implement cardiovascular risk reduction: smoking cessation, control of hypertension and dyslipidemia, and prescribe low-dose aspirin or clopidogrel. 3, 5, 4
• Address malnutrition and edema, as these impair post-surgical healing. 5, 7

Long-Term Surveillance

• Establish lifelong surveillance of the surgical site and all significant scars or areas of chronic inflammation, as recurrence risk persists. 1, 2
• Monitor for local recurrence at the excision site and assess regional lymph nodes at each follow-up visit. 2
• The 5-year mortality rate for diabetic foot ulcers is approximately 30%, and exceeds 70% for those requiring major amputation. 8

Multidisciplinary Team Approach

• Coordinate care through a multidisciplinary team including surgical oncology (for tumor excision), vascular surgery (for revascularization if needed), infectious disease (for infection management), podiatry, and wound care specialists. 3, 8
• Multidisciplinary care is associated with significantly lower major amputation rates (3.2% vs 4.4%) compared to usual care. 8

Critical Pitfalls to Avoid

• Do not delay biopsy of chronic non-healing ulcers—early diagnosis of malignant transformation is essential for successful treatment. 1, 2
• Do not attempt conservative wound care for confirmed malignancy—surgical excision is the only curative treatment. 1, 2
• Do not perform tumor excision without first ensuring adequate arterial perfusion, as ischemia will prevent surgical wound healing. 3, 4
• Do not accept inadequate surgical margins—insufficient excision leads to recurrence and metastasis. 1
• Do not use advanced wound therapies (growth factors, bioengineered skin products, hyperbaric oxygen) as substitutes for definitive surgical excision. 3, 6